| dbo:abstract
|
- Merrimack Pharmaceuticals is a pharmaceutical company based in Cambridge, Massachusetts, United States. They specialize in developing drugs for the treatment of cancer. Merrimack's first FDA-approved drug was approved in 2015; Onivyde, a liposome encapsulated version of irinotecan is used for treating pancreatic adenocarcinoma. It was approved for use in the European Union the following year. (en)
|
| dbo:foundingYear
| |
| dbo:locationCity
| |
| dbo:locationCountry
| |
| dbo:numberOfEmployees
|
- 426 (xsd:nonNegativeInteger)
|
| dbo:type
| |
| dbo:wikiPageExternalLink
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 5390 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:founded
| |
| dbp:hqLocationCity
| |
| dbp:hqLocationCountry
| |
| dbp:industry
| |
| dbp:name
|
- Merrimack Pharmaceuticals (en)
|
| dbp:numEmployees
| |
| dbp:numEmployeesYear
| |
| dbp:tradedAs
|
- Russell Microcap Index component (en)
- NASDAQ:MACK (en)
|
| dbp:type
| |
| dbp:website
| |
| dbp:wikiPageUsesTemplate
| |
| dcterms:subject
| |
| rdf:type
| |
| rdfs:comment
|
- Merrimack Pharmaceuticals is a pharmaceutical company based in Cambridge, Massachusetts, United States. They specialize in developing drugs for the treatment of cancer. Merrimack's first FDA-approved drug was approved in 2015; Onivyde, a liposome encapsulated version of irinotecan is used for treating pancreatic adenocarcinoma. It was approved for use in the European Union the following year. (en)
|
| rdfs:label
|
- Merrimack Pharmaceuticals (en)
|
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:homepage
| |
| foaf:isPrimaryTopicOf
| |
| foaf:name
|
- Merrimack Pharmaceuticals (en)
|
| is dbo:wikiPageDisambiguates
of | |
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
